Our companion guide to trauma-focused therapy covers the specific techniques used to treat trauma in addiction settings. This piece steps back to the bigger question underneath that: how PTSD and substance use disorder, two conditions that reinforce each other in a well-documented cycle, actually get treated when they occur together, and why the field's approach to sequencing this treatment has shifted meaningfully in recent years.
The relationship between trauma and substance use is not coincidental. The self-medication hypothesis, well established in addiction research, describes how people often turn to alcohol or drugs specifically to manage the intrusive memories, hyperarousal, and emotional numbing characteristic of PTSD. This creates a genuinely self-reinforcing cycle: substances provide short-term relief from trauma symptoms, but the avoidance this represents, avoiding the emotional processing that actual recovery from trauma requires, tends to keep PTSD symptoms entrenched over the longer term, which in turn deepens reliance on the substance for relief. Research consistently finds this comorbidity is highly prevalent, and clinical literature specifically notes that effective treatments addressing both conditions together have historically been in short supply, which is precisely the gap more recent integrated treatment models have been built to fill.
This comorbidity also tends to carry a worse overall prognosis than either condition alone. Research has found that PTSD and substance use disorder occurring together is associated with worse treatment outcomes in standard substance use programs and a higher rate of crisis interventions than substance use disorder without co-occurring PTSD. This is part of why international clinical guidelines have specifically called for treatment approaches that address the trauma directly, rather than treating it as a secondary concern to be revisited only after addiction treatment has run its course; leaving trauma unaddressed is itself associated with a harder, less stable recovery from the substance use disorder.
For years, addiction treatment operated on a largely sequential model for this comorbidity: stabilize the substance use disorder first, through detox and early sobriety, and address the trauma separately, often much later, sometimes in an entirely different treatment episode. The logic made intuitive sense, avoid destabilizing an already fragile recovery with difficult trauma work, but it also meant the underlying driver of substance use, in cases where trauma was genuinely central, often went unaddressed for extended periods, sometimes allowing the self-medication cycle to continue uninterrupted.
Integrated treatment models reject this strict sequencing, working on both conditions concurrently rather than one after the other. International clinical guidelines have increasingly moved toward recommending this integrated approach specifically because research has found it produces better outcomes, particularly for the PTSD side of the comorbidity, than treating substance use in isolation and leaving trauma for later.
Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE), developed by researchers including Sudie Back and Edna Foa, is the most rigorously studied integrated, exposure-based treatment for this specific comorbidity. It combines Prolonged Exposure therapy for PTSD with cognitive-behavioral relapse prevention skills for substance use, delivered across 12 structured 90-minute sessions that include both imaginal exposure to the traumatic memory and in-vivo exposure to avoided real-world situations.
A randomized controlled trial in military veterans found COPE produced significantly greater reductions in PTSD symptom severity than a standard relapse prevention control condition, with a large effect size, and significantly higher rates of PTSD diagnostic remission. Critically, substance use outcomes improved comparably in both groups, meaning the addition of direct trauma processing did not come at the cost of worse addiction outcomes, directly countering the older assumption that this kind of work is too destabilizing for people with active substance use disorders. Separate research on COPE specifically examined whether distress and craving during the exposure sessions predicted a return to substance use afterward, and found no such association, further undermining the rationale behind the older sequential model.
COPE's structure is worth understanding in a bit more detail, since it illustrates how integration actually works in practice rather than simply meaning two separate treatments delivered in the same building. Each session weaves together components addressing both conditions: psychoeducation about how PTSD symptoms and substance use interact, specific techniques for managing cravings and urges to use, relapse prevention coping skills, and the exposure work itself. Treatment goals are collaboratively defined with the patient and can include either full abstinence or a reduction in substance use, reflecting a degree of flexibility that acknowledges different patients may be working toward different immediate goals even within the same structured protocol. This integration at the level of individual sessions, rather than simply scheduling both treatments in parallel, is part of what distinguishes a genuinely integrated model from two separate treatments delivered side by side.
None of this means integrated treatment is automatically right for everyone, or that sequential treatment is now obsolete. Someone in acute, unstabilized withdrawal, or facing an immediate safety crisis, may genuinely need a period of stabilization before either COPE or another trauma-processing approach is appropriate. This is a clinical judgment made individually, based on a person's specific presentation, not a fixed rule applied uniformly. What has changed is the default assumption: rather than automatically delaying trauma work for an extended, often unspecified period, current best practice generally treats concurrent, integrated care as the goal to work toward as soon as it is clinically appropriate, rather than as an option reserved only for people who have already achieved long-term stable sobriety.
Consider a veteran entering treatment with both alcohol use disorder and PTSD stemming from combat exposure, who has cycled through two prior rounds of alcohol-focused treatment without ever directly addressing the trauma. In a strictly sequential model, trauma work might again be deferred indefinitely, treating this admission as simply another attempt at sobriety alone. In an integrated model using COPE, treatment addresses both conditions from the outset, once initial medical stabilization is complete, with the explicit working hypothesis that unprocessed trauma has been a central driver of the repeated relapses. The research on COPE specifically supports this approach for a population very similar to this scenario, having been developed and validated substantially through work with military veterans.
- Ask directly whether the program offers integrated PTSD and substance use treatment, or treats these as entirely separate, sequential processes
- If trauma-focused, exposure-based therapy like COPE or Prolonged Exposure is offered, ask about the specific clinician's training in delivering it alongside active addiction treatment
- If a program insists on lengthy stabilization before any trauma work begins, ask what specific clinical criteria determine when that stabilization is considered complete, rather than accepting an open-ended timeline
- Understand that both PTSD and substance use symptoms may fluctuate during active, integrated treatment, and ask how the program distinguishes expected treatment-related distress from a genuine safety concern requiring a different response
Our companion guide to trauma-focused therapy techniques covers what these specific approaches, including Seeking Safety and EMDR, actually look like in session, and our guide to depression and substance use disorder covers a related but distinct diagnostic challenge worth understanding alongside this one.
Frequently asked questions
The self-medication hypothesis describes how people often use alcohol or drugs to manage PTSD symptoms like intrusive memories and hyperarousal, but this avoidance keeps PTSD entrenched, creating a self-reinforcing cycle.
Sequential treatment stabilizes substance use first and addresses trauma later, sometimes much later. Integrated treatment works on both conditions concurrently, which current research generally supports as producing better outcomes.
Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure, an integrated therapy combining Prolonged Exposure for PTSD with relapse prevention skills for substance use, delivered across 12 structured sessions.
Research on COPE found distress and craving during exposure sessions was not associated with an increased return to substance use afterward, directly countering the older assumption that this work is too destabilizing.
A randomized controlled trial in military veterans found COPE produced significantly greater reductions in PTSD symptoms and higher rates of diagnostic remission than a relapse prevention control, with comparable improvements in substance use for both groups.
Not automatically. Someone in acute, unstabilized withdrawal may need a period of stabilization first. Current best practice treats integrated care as the goal to work toward as soon as clinically appropriate, not a fixed rule for every case.
This article was reviewed by the RehabsNearMe Editorial Team for accuracy, clarity, and relevance. Information may be sourced from publicly available treatment resources, government agencies, and healthcare references where applicable.
Last reviewed: September 2026
Related articles
Resources
